by Sue Robbins | Jun 25, 2015 | Adolescents and Children, Headache Drugs
A study presented last week at the 57th Annual Scientific Meeting of the American Headache Society has found that too many children suffering with migraines are not getting any medication for their pain and too few are receiving care consistent with evidence-based...
by Sue Robbins | Jun 24, 2015 | Headache Drugs
Results from the largest-ever study to track real-time adherence to triptans during an extended time were presented at the American Headache Society 57th Annual Scientific Meeting. “We know that triptans work really well for a majority of patients with migraine....
by Sue Robbins | Jan 15, 2015 | Headache Drugs
The American Migraine Foundation is seeking funding to create the first-ever Migraine Patient Registry and Biorepository. The foundation, a nonprofit organization supported by the American Headache Association, hopes this international database will help to boost...
by Sue Robbins | Oct 9, 2014 | Headache Drugs
A new phase 2 trial of ALD403, a humanized monoclonal antibody directed against calcitonin gene-related peptide (CGRO) showed that the drug was safe and effective. Although preliminary, the results are promising, said lead author, David W. Dodick, professor,...
by Sue Robbins | May 14, 2014 | Headache Drugs
An observational study was recently done by several fellows of the American Headache Society Headache Fellows Research Consortium. While it is generally believed that patient education and patient knowledge regarding triptan use for acute migraine management are...
